27 March 2019 - Deborah Wilkes
Archived
Regulators should "avoid the temptation to overexaggerate risks connected to medicines", according to Hugo Hurts, executive director of the Dutch Medicines Evaluation Board (MEB).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.